Search Results - "Middendorf, Charlotte"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Abstract 5000: YB-1 based oncolytic virotherapy in combination with small molecular inhibitors for treatment of refractory osteosarcoma

    Abstract 5000: YB-1 based oncolytic virotherapy in combination with small molecular inhibitors for treatment of refractory osteosarcoma by Middendorf, Charlotte Friederike, Schober, Sebastian Johannes, Kordass, Corazón, Nawroth, Roman, Burdach, Stefan E., Holm, Per Sonne, Thiel, Uwe

    Published in Cancer research (Chicago, Ill.) (15-08-2020)
    “…This in vitro study evaluates YB-1 based oncolytic virotherapy in combination with molecular target therapy as a novel therapeutic strategy for refractory…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma

    The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma by Schober, Sebastian Johannes, Schoening, Caroline, Eck, Jennifer, Middendorf, Charlotte, Lutsch, Julia, Knoch, Pia, von Ofen, Anna Josefine, Gassmann, Hendrik, Thiede, Melanie, Hauer, Julia, Kolk, Andreas, Mantwill, Klaus, Gschwend, Jürgen E, Burdach, Stefan E G, Nawroth, Roman, Thiel, Uwe, Holm, Per Sonne

    Published in Clinical cancer research (15-05-2023)
    “…Ewing sarcoma (EwS) is a highly malignant pediatric tumor characterized by a non-T-cell-inflamed immune-evasive phenotype. When relapsed or metastasized,…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: